Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Prostate Cancer|Non-Small Cell Lung Cancer|Breast Cancer
Interventions: DRUG: RQ-00000007|DRUG: Gemcitabine
Sponsor: University of Maryland, Baltimore